Annika Muskantor

Annika Muskantor

Geen lopende functies
60 jaar
Health Technology
Consumer Services
Technology Services

Profiel

Annika Muskantor served as the Chief Financial Officer at Oncopeptides AB from 2021 to 2023.
Prior to that, she worked as the Interim Chief Financial Officer at Dun & Bradstreet AB. In 2012 to 2013, she held the position of Chief Financial Officer at Swedish Orphan Biovitrum AB. From 2019 to 2021, she served as the Chief Financial Officer at FRISQ Holding AB. Ms. Muskantor also worked as an Interim Chief Financial Officer at Zodiak Media AB, eBay Sweden Services AB, and Scienta Omicron AB. She was the Chief Financial Officer at Ganni A. Currently, she is the Chief Financial Officer at Net Insight AB. Ms. Muskantor completed her undergraduate studies at Northwestern University and holds an MBA from Kellogg School of Management.

Eerdere bekende functies van Annika Muskantor

BedrijvenFunctieEinde
NET INSIGHT AB Financieel Directeur/CFO 14-08-2024
ONCOPEPTIDES AB Financieel Directeur/CFO 18-01-2023
Financieel Directeur/CFO 31-03-2021
SWEDISH ORPHAN BIOVITRUM AB Financieel Directeur/CFO 08-04-2013
Financieel Directeur/CFO -
Ervaring van Annika Muskantor in detail bekijken

Opleiding van Annika Muskantor

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

22

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Electronic Technology

Consumer Services

Health Technology

Technology Services

Health Technology

Consumer Non-Durables

Consumer Services

Technology Services

Consumer Services

Technology Services

Health Technology

  1. Beurs
  2. Insiders
  3. Annika Muskantor